Novartis to acquire Avidity Biosciences for about $12 billion

Novartis to acquire Avidity Biosciences for about $12 billion
Source link

Novartis to acquire Avidity Biosciences for about $12 billion
Source link
In the relentless marathon of technological innovation – even the swiftest runners can stumble. If you’ve been watching the Olympics at all – you’ve seen this time and again… Now, imagine being one of these world-class athletes and pulling a hamstring mid-race. Now imagine instead of being an athlete – you’re a tech giant that…
Watch this video on YouTube!youtu.be/Y7iHhiAJHFI Stocks Manage to Hold On to GainsDollar Bounces for 3rd WeekGold Could Be in TroubleSolana, Ethereum Bounce as Bitcoin Approaches Records Stocks Covered In Members Only Video:Market BreadthCrude Oil, Natural Gas, SPY, DIA, QQQ, IWM, Communication Services, Financials, Technology, Real Estate, MLPs, China Internet, AustraliaAmerican Express, Boeing, Bank of America, Disney,…
Is The Market Recognizing Veralto's Quality? Source link
May 22, 2025May 22, 2025 Shares of Venus Remedies Ltd rose 1% to hit a day’s high of Rs 361.95 on 22nd May after the company said it had renewed its GMP (Good Manufacturing Practices) certification from Ukraine’s regulatory body for its Unit-II facility in…
Emkay Global has a ‘buy’ rating on Metropolis Healthcare and a target price of Rs 2,200, a potential upside of 12.2%. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) Source link
by Calculated Risk on 12/10/2025 07:26:00 PM Note: Mortgage rates are from MortgageNewsDaily.com and are for top tier scenarios. Thursday:• At 8:30 AM ET, The initial weekly unemployment claims report will be released. There were 191,000 initial claims last week. • Also at 8:30 AM, Trade Balance report for September from the Census Bureau. The…